AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma
Authors: Matsuo, K Takenaka, K Shimomura, H Fujii, N Shinagawa, K Kiura, K Harada, M
Citation: K. Matsuo et al., Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma, LEUK LYMPH, 41(1-2), 2001, pp. 191-195
Cytomegalovirus enteritis after autologous peripheral blood stem cell transplantation
Authors: Kozuka, T Takenaka, K Shinagawa, K Masuda, K Ishihara, T Arimori, Y Fukunaga, S Maeda, Y Ishimaru, E Kiura, K Ikeda, K Niiya, K Harada, M
Citation: T. Kozuka et al., Cytomegalovirus enteritis after autologous peripheral blood stem cell transplantation, ANN HEMATOL, 80(10), 2001, pp. 617-619
Giant negative T waves during interferon therapy in a patient with chronichepatitis C
Authors: Fujiwara, T Kiura, K Ochi, K Matsubara, H Yamanari, H Shimomura, H Harada, M
Citation: T. Fujiwara et al., Giant negative T waves during interferon therapy in a patient with chronichepatitis C, INTERN MED, 40(2), 2001, pp. 105-109
Successful treatment with concurrent chemoradiotherapy followed by surgeryfor a patient with thymic adenocarcinoma
Authors: Shimono, M Hiraki, A Ueoka, H Tanimoto, Y Aoe, M Sakae, K Kaneda, K Sakugawa, M Kiura, K Harada, M
Citation: M. Shimono et al., Successful treatment with concurrent chemoradiotherapy followed by surgeryfor a patient with thymic adenocarcinoma, ANTICANC R, 21(4A), 2001, pp. 2519-2522
Generation of cytotoxic T lymphocytes against autologous lung cancer cellsresistant to apoptosis
Authors: Hiraki, A Ono, T Tanaka, M Kiura, K Ueoka, H Kawai, H Harada, M Nakayama, E Noguchi, Y
Citation: A. Hiraki et al., Generation of cytotoxic T lymphocytes against autologous lung cancer cellsresistant to apoptosis, ANTICANC R, 21(4A), 2001, pp. 2561-2567
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)
Authors: Shibayama, T Ueoka, H Nishii, K Kiura, K Tabata, M Miyatake, K Kitajima, T Harada, M
Citation: T. Shibayama et al., Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC), LUNG CANC, 32(1), 2001, pp. 61-69
Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells
Authors: Kiguchi, T Niiya, K Shibakura, M Miyazono, T Shinagawa, K Ishimaru, F Kiura, K Ikeda, K Nakata, Y Harada, M
Citation: T. Kiguchi et al., Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells, INT J CANC, 93(6), 2001, pp. 792-797
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
Authors: Ueoka, H Tanimoto, M Kiura, K Tabata, M Takigawa, N Segawa, Y Takata, I Eguchi, K Okimoto, N Harita, S Kamei, H Shibayama, T Watanabe, Y Hiraki, S Harada, M
Citation: H. Ueoka et al., Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group, BR J CANC, 85(1), 2001, pp. 9-13
Tumor-specific cytotoxic T lymphocyte responses against chondrosarcoma with HLA haplotype loss restricted by the remaining HLA class I allele
Authors: Hiraki, A Ikeda, K Yoshino, T Kaneshige, T Kiura, K Kunisada, T Fujiwara, K Tanimoto, M Harada, M
Citation: A. Hiraki et al., Tumor-specific cytotoxic T lymphocyte responses against chondrosarcoma with HLA haplotype loss restricted by the remaining HLA class I allele, BIOC BIOP R, 286(4), 2001, pp. 786-791
Allogeneic peripheral blood stem cell transplantation in 23 adult patientswith hematologic malignancies: A single-center experience
Authors: Takenaka, K Shinagawa, K Sunami, K Fujii, N Hiramatsu, Y Maeda, Y Nawa, Y Katayama, Y Teshima, T Ishimaru, F Kiura, K Ikeda, K Harada, M
Citation: K. Takenaka et al., Allogeneic peripheral blood stem cell transplantation in 23 adult patientswith hematologic malignancies: A single-center experience, INT J HEMAT, 72(3), 2000, pp. 362-370
Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis
Authors: Maeda, T Ueoka, H Tabata, M Kiura, K Shibayama, T Gemba, K Takigawa, N Hiraki, A Katayama, H Harada, M
Citation: T. Maeda et al., Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis, JPN J CLIN, 30(12), 2000, pp. 534-541
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer
Authors: Takigawa, N Segawa, Y Ueoka, H Kiura, K Tabata, M Shibayama, T Takata, I Miyamoto, H Eguchi, K Harada, M
Citation: N. Takigawa et al., Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer, CANC CHEMOT, 46(4), 2000, pp. 272-278
Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction
Authors: Bessho, A Tabata, M Kiura, K Takata, I Nagata, T Fujimoto, N Kunisada, K Ueoka, H Harada, M
Citation: A. Bessho et al., Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction, ANTICANC R, 20(2B), 2000, pp. 1149-1154
Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer
Authors: Fujimoto, N Hiraki, A Ueoka, H Kiura, K Bessho, A Takata, I Hiramatsu, Y Ikeda, K Harada, M
Citation: N. Fujimoto et al., Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer, LUNG CANC, 30(2), 2000, pp. 145-148
Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome
Authors: Gemba, K Ueoka, H Kiura, K Tabata, M Harada, M
Citation: K. Gemba et al., Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome, LUNG CANC, 29(1), 2000, pp. 23-31
(-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice
Authors: Mimoto, J Kiura, K Matsuo, K Yoshino, T Takata, I Ueoka, H Kataoka, M Harada, M
Citation: J. Mimoto et al., (-)-epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice, CARCINOGENE, 21(5), 2000, pp. 915-919
SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line
Authors: Motoda, K Takata, M Kiura, K Nakamura, I Harada, M
Citation: K. Motoda et al., SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line, IMMUNOLOGY, 100(3), 2000, pp. 370-377
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
Authors: Segawa, Y Ueoka, H Kiura, K Kamei, H Tabata, M Sakae, K Hiraki, Y Kawahara, S Eguchi, K Hiraki, S Harada, M
Citation: Y. Segawa et al., A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group, BR J CANC, 82(1), 2000, pp. 104-111
Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer
Authors: Hiraki, A Kaneshige, T Kiura, K Ueoka, H Yamane, H Tanaka, M Harada, M
Citation: A. Hiraki et al., Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer, CLIN CANC R, 5(4), 1999, pp. 933-936
Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: Diagnosis and treatment
Authors: Hiraki, A Ueoka, H Yoshino, T Chikamori, KI Onishi, K Kiura, K Bessho, A Mimoto, J Date, H Ando, A Shimizu, N Harada, M
Citation: A. Hiraki et al., Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: Diagnosis and treatment, ONCOL REP, 6(1), 1999, pp. 75-80
Very young patient with peculiar squamous cell carcinoma of the lung
Authors: Emori, Y Kiura, K Yoshino, T Notohara, K Tsuchida, T Yokoyama, M Nogami, N Kataoka, M Ueoka, H Harada, M
Citation: Y. Emori et al., Very young patient with peculiar squamous cell carcinoma of the lung, INTERN MED, 38(12), 1999, pp. 979-983
Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer
Authors: Yamane, H Bessho, A Kiura, K Tabata, M Katayama, Y Motoda, K Tsuchida, T Nogami, N Hiraki, A Ueoka, H Harada, M
Citation: H. Yamane et al., Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer, INTERN MED, 38(11), 1999, pp. 892-895
Establishment of a drug sensitivity panel using human lung cancer cell lines
Authors: Matsushita, A Tabata, M Ueoka, H Kiura, K Shibayama, T Aoe, K Kohara, H Harada, M
Citation: A. Matsushita et al., Establishment of a drug sensitivity panel using human lung cancer cell lines, ACT MED OKA, 53(2), 1999, pp. 67-75
In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines
Authors: Ikubo, S Takigawa, N Ueoka, H Kiura, K Tabata, M Shibayama, T Chikamori, M Aoe, K Matsushita, A Harada, M
Citation: S. Ikubo et al., In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines, ANTICANC R, 19(5B), 1999, pp. 3985-3988
High-dose ifosfamide, carboplatin and etoposide with autologous peripheralblood progenitor cell transplantation for small-cell lung cancer
Authors: Bessho, A Ueoka, H Kiura, K Tabata, M Sunami, K Katayama, Y Yamane, H Hiraki, A Harada, M
Citation: A. Bessho et al., High-dose ifosfamide, carboplatin and etoposide with autologous peripheralblood progenitor cell transplantation for small-cell lung cancer, ANTICANC R, 19(1B), 1999, pp. 693-698
Risultati: 1-25 | 26-27